Alliancebernstein L.P. Kymera Therapeutics, Inc. Call Options Transaction History
Alliancebernstein L.P.
- $290 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KYMR
# of Institutions
225Shares Held
72.9MCall Options Held
178KPut Options Held
64.6K-
Price T Rowe Associates Inc Baltimore, MD6.86MShares$410 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.65MShares$397 Million2.94% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.56MShares$391 Million5.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.62MShares$336 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA5.5MShares$329 Million9.44% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $3.27B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...